Ersek Mary, Miller Susan C, Wagner Todd H, Thorpe Joshua M, Smith Dawn, Levy Cari R, Gidwani Risha, Faricy-Anderson Katherine, Lorenz Karl A, Kinosian Bruce, Mor Vincent
Veteran Experience Center (formerly the PROMISE Center), Corporal Michael J. Crescenz VA Medical Center, Philadelphia, Pennsylvania.
University of Pennsylvania School of Nursing, Philadelphia, Pennsylvania.
Cancer. 2017 Aug 15;123(16):3186-3194. doi: 10.1002/cncr.30700. Epub 2017 Apr 17.
To the authors' knowledge, little is known regarding the relationship between patients' and families' satisfaction with aggressive end-of-life care. Herein, the authors examined the associations between episodes of aggressive care (ie, chemotherapy, mechanical ventilation, acute hospitalizations, and intensive care unit admissions) within the last 30 days of life and families' evaluations of end-of-life care among patients with non-small cell lung cancer (NSCLC).
A total of 847 patients with NSCLC (34% of whom were aged <65 years) who died in a nursing home or intensive care, acute care, or hospice/palliative care (HPC) unit at 1 of 128 Veterans Affairs Medical Centers between 2010 and 2012 were examined. Data sources included Veterans Affairs administrative and clinical data, Medicare claims, and the Bereaved Family Survey. The response rate for the Bereaved Family Survey was 62%.
Greater than 72% of veterans with advanced lung cancer who died in an inpatient setting had at least 1 episode of aggressive care and 31% received chemotherapy within the last 30 days of life. For all units except for HPC, when patients experienced at least 1 episode of aggressive care, bereaved families rated care lower compared with when patients did not receive any aggressive care. For patients dying in an HPC unit, the associations between overall ratings of care and ≥2 inpatient admissions or any episode of aggressive care were not found to be statistically significant. Rates of aggressive care were not associated with age, and family ratings of care were similar for younger and older patients.
Aggressive care within the last month of life is common among patients with NSCLC and is associated with lower family evaluations of end-of-life care. Specialized care provided within an HPC unit may mitigate the negative effects of aggressive care on these outcomes. Cancer 2017;123:3186-94. © 2017 American Cancer Society.
据作者所知,关于患者及其家属对积极的临终关怀的满意度之间的关系,人们了解甚少。在此,作者研究了生命最后30天内的积极治疗(即化疗、机械通气、急性住院和重症监护病房入院)与非小细胞肺癌(NSCLC)患者家属对临终关怀的评价之间的关联。
对2010年至2012年间在128家退伍军人事务医疗中心中的1家养老院、重症监护、急性护理或临终关怀/姑息治疗(HPC)病房死亡的847例NSCLC患者(其中34%年龄小于65岁)进行了研究。数据来源包括退伍军人事务管理和临床数据、医疗保险理赔以及丧亲家庭调查。丧亲家庭调查的回复率为62%。
在住院环境中死亡的晚期肺癌退伍军人中,超过72%在生命的最后30天内至少经历了1次积极治疗,31%接受了化疗。除HPC外的所有病房,当患者至少经历1次积极治疗时,与未接受任何积极治疗的患者相比,丧亲家属对护理的评价更低。对于在HPC病房死亡的患者,未发现护理总体评价与≥2次住院或任何积极治疗事件之间的关联具有统计学意义。积极治疗率与年龄无关,年轻患者和老年患者的家属对护理的评价相似。
生命最后一个月内的积极治疗在NSCLC患者中很常见,并且与家属对临终关怀的较低评价相关。HPC病房提供的专科护理可能会减轻积极治疗对这些结果的负面影响。《癌症》2017年;123:3186 - 94。©2017美国癌症协会。